LEXINGTON, Mass.--(BUSINESS WIRE)--April 20, 2006--Critical Therapeutics, Inc. (Nasdaq: CRTX - News), a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, today announced that its senior management is scheduled to present at the following investor conferences:
